Inflammasome – Gut microflora link to Metabolic syndrome; A case for metagenomics

Metabolic syndrome so far is attributed to the deregulation of the metabolic processes leading to increase triglycerides, fat, insulin resistance etc. and thereby leading to diabetes mellitus, coronary heart disease and hypertension. Inflammation is also one of the key factors that can cause an onset of metabolic syndrome.

Recently, a new article in Cell Research (a Nature publication) puts a new perspective on the role of gut micro biota as a causative effect in the process of inflammatory response in the liver (http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201255a.html)

The article highlights certain interesting points and hypothesizes that defective inflammasome signaling in the gastro-intestinal tract allows colitogenic microbes to prosper in the colon, and subsequently trigger harmful inflammatory signaling pathways in systemic organs when the gastro-intestinal barrier is breached. The fact that defective inflammasome signalling can skew the gut micro biota towards colitogenic species of the Prevotellaceae family and the candidate phylum TM7 is not only interesting but opens a new dimension on the role of intestinal “niche” environment in regulating the microbiota species and thereby controlling different aspects of well being of humans (though the research highlighted above is in mice).

Role of gut microbes in maintaining robust immune system or even mental health have been reported earlier. In this era of genomics, it is therefore imperative that we use metagenomics to study gut microflora to understand the intestinal “niche” microenvironment. This would help in designing better targeted antibiotics for therapeutical intervention and thereby possible prevention of many of today’s lifestyle diseases!

Personalized Medicine – Ethics Vs Need

In this era of modern genomic tools, it is getting pretty much apparent that we are closing in on a scenario where in the genome of an individual can be sequenced in a matter of few hours. Question 1)– What do we intend to do with it? Question 2)- Sequencing is just one part of the puzzle but do we actually understand the finer details? Now, assuming that the bioinformatics hurdles are taken care of, then with the important data in hand how do we proceed? How much do we disclose to the patients? How much should the physicians or relatives know? Well, in other words it is the ethics versus need debate. Recent article in American medical news throws some light on this (http://www.ama-assn.org/amednews/2012/04/02/hll20402.htm)

Step towards personalized medicine is not only about the hardware/software part of it but also it is about proper training at physician, geneticists and lab scientists’ level. First is to have a meaningful understanding of the data which can be made ‘easy to understand’ for the care giver (physicians). Then comes the question of what sort of data should be discussed with the patient and their relatives. This is a tricky scenario as unless we as scientific community is absolutely clear of the data and the predisposition risks therefore, I guess it would not be good idea to share such info with patients as they would be upset and would get scared. 

There is a section in the community that believes that family history of the patients should be looked into and only diseases which a patient is predisposed to should be looked into in detail. I would presume it is a thought in the right direction; however, it defeats the whole purpose of whole genome sequencing. Also, as our genome stores a treasure trove of data, it is important to know what else we are predisposed to apart from what our family history suggests! Another ethical issue which might crop up in the near future is that people may want to see the ‘genome map’ of a prospective partner before marriage to avoid getting genetic diseases in the offspring. Now, this might be good but it might lead to all sort of complications and less randomization of the gene pool!!!

Finally, if the people are made more aware, whole genome sequencing, in the future would let us take preventive measures knowing what is in store for us (not astrologically but genetically) and be better prepared for any eventuality.

Reliable research – Where are we going wrong?

Like any field and probably contrary to beliefs, life in research is very frustrating. The chances of success are minimal. The scientists not only need to worry about the failed experiments but also worry about the peer pressure, the rat race to publish and publish for the sake of getting new grants and also continuance of the old grants. After all a scientist is worth how much grants he has or how many publications he has.

But in doing all this, we as scientific community are doing a great disservice to the field of science. Many of the published articles are either not genuine or are not reproducible. The beauty of research is that an observation in one part of the world can and should be faithfully reproduced anywhere else provided the reagents are of the same quality and of course the experiments are repeated as were done in the original research. However, still, most of the research goes the non-reproducible way!!! Now this is a big blot on the credibility of the scientific research community. The basic research is the template on which newer medicines would be based. And one recent article in Reuters (http://www.reuters.com/article/2012/03/28/us-science-cancer-idUSBRE82R12P20120328) highlights the pitfalls of such a alarming scenario.

There needs to be a mechanism that would and should delink a scientists’ credibility from the number of research articles published otherwise this problem can take a serious turn for the worse!!!!

Predicament of a researcher

Researcher is like an artist, getting pleasure from his creations (discoveries or inventions). And like artists, the researchers at heart are more worried about the theories and pathways rather than the business of it.

However, in this day and age, research needs a lot of capital to start with and to sustain. And in the rush of producing “data”, the real focus shifts from good research to just noise. Thousands of papers are published in as many journals but most of them are not even worth the paper they are printed in.  But in this “kalyuga”, it is important to get the recognition and the grant going hence the odd saga continues.................

When the world economy is going for a spin, who bothers about the research or researchers. People who bring business become more important for an organization. But we all forget, that society, economy and life for that matter is dependent on constant innovation. Science and scientific innovations are making our lives worth living but scientists are the least paid and looked after.

Isn’t it time we realized this folly? Corrective mindsets are need of the hour or else as falling sex ratio in many regions of India is a major problem, soon dearth of people taking up research or scientists leaving research would push India back..............

Mental illness - an appalling state of affairs

Depression is a simple word but has a devastating meaning. It is a disease which ruins not only the individual but also affects the entire family. Particularly in today’s day and life when stress (both professional and personal) is slowly gripping the society, cases of depression have been skyrocketing.  Talking about mental illness however, has been a taboo in our society. People afflicted with such diseases are socially boycotted. It is time when people, government realized the impact such an ailment has on the society. Western countries are a shade better when it comes to the acceptance of mental ailment and availability of healthcare workers, psycho analysts and psychiatrists to deal with such issues. But it is in an appalling state in our country.

The area of research and treatment in this field is also fraught with naivety and is not very advanced. Even there are no credible biomarkers to diagnose such ailments; it solely depends on the profiling done by the psychiatrist. We still do not know the mechanism of action of some of the drugs and doubts persist about their effectiveness as therapies. Patients even avoid taking these drugs as they are unsure of the possible ‘side-effects’ of these molecules. Yes, research on brain is a very difficult proposition, yes; it requires cutting edge technologies probably in the edge of what science can offer today and yes we are years if not probably decades away from a ‘cure’ to most of these ailments. But having said that, are we spending enough in this field? Are the pharma companies/Governments doing enough? Of course the cash cows for the industry remains cancer, diabetes etc. but if do not look deeper into the problem and increase funding and research into this field then the cost of dealing with the outcome would be dangerously high!

Modern Genomic technologies - an exciting era

The next generation sequencing and microarray technologies have transformed the way questions in biology are being answered today. The technology is ever evolving and at a pace rivalled only by the information technology sector. The future would be even more exciting as fast paced developments not only at the hardware side but at the software side(bioinformatics included) are envisioned that would take the life science industry forward.

                                                                                                                                                

Diabetes cure - a fresh approach is the need of the hour

We are in the 21^st century. A new millennium and a hope that new discoveries, innovations would help us thwart diseases like cancer, diabetes, schizophrenia etc. Actually, if we leave the mental illness aside for a minute as the science studying mind/brain is pretty nascent; then one would ponder why we are still years if not decades away from finding a credible cure for diseases like cancer, diabetes and HIV! Right now we only treat diseases like diabetes not cure them………………….

Let’s talk about diabetes, type 2 to be precise for a moment. The best medicine for decades to treat (not cure, mind it!) has been metformin. This humble drug has shown tremendous resilience in terms of safety and efficacy and is and probably would be the first line of therapy for years to come!

 The current or upcoming therapies for diabetes mostly revolve around two aspects – a) increasing insulin secretion (sulphonylureas take the cake here) or b) increasing insulin sensitivity (PPARs/metformin etc). Even the new ones like the GLP-1s or DPP-IV inhibitors ultimately increase insulin secretion though independent of glucose concentration (better than sulphonylureas!). But to me these are just like “cosmetic” drugs treating the symptom not the cause and I feel that we have still not properly understood this disease. In this context, I would like to share a new discovery that can change the perception of how we look at type 2 diabetes.  New research has suggested that the development of insulin resistance and type 2 diabetes may be linked to an immune system reaction gone awry. Till now, we have been looking at type 2 diabetes as a metabolic disease and immune system malaise is mostly associated with the other cousin of diabetes , the type 1 diabetes. Now, if the above said observation is indeed found to be credible in subsequent research then it would mean a tremendous paradigm shift in type 2 diabetes research. I guess, this kind of observation/research is the step in the right direction to understand the cause of the disease.

Probably, joining the pieces of the diabetes puzzle through innovative and fresh thinking is the right approach to finding a “cure” for this scourge rather than trying to better the current therapies to “treat” the disease.